Clinical Trial Update: Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Linperlisib in combination with CHOP for previously untreated Peripheral T-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Linperlisib (linperlisib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Peripheral T-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING